0.2590EUR-28.25%Mkt Cap: 1.52M EURP/E: —Last update: 2026-05-14
IntegraGen SA provides researchers with sequencing solutions, data management tools, and biostatistical, and bioinformatics support services in France. The company's genomic pharma services DNA sequencing for oncology an…
Industry Peers
Biotechnologyloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
P/B-1.67
P/S0.30
EV/EBITDA-0.26
EV/Revenue0.14
EPS (TTM)-0.04
EPS (Forward)—
Cash Flow & Leverage
FCF Yield-10.90%
FCF Margin-3.31%
Operating CF-1.58M EUR
CapEx (TTM)—
Net Debt/EBITDA0.30
Net Debt-810.61K EUR
Technical
SMA 500.1851 (+39.9%)
SMA 2000.1814 (+42.8%)
Beta0.33
S&P 52W Chg24.23%
Avg Vol (30d)21.79K
Avg Vol (10d)52.97K
Technical Indicators
RSI (14)58.6
MACD0.0254
MACD Signal0.0106
MACD Hist.+0.0148
BB Upper0.2983 EUR
BB Middle0.1940 EUR
BB Lower0.0897 EUR
BB Width107.48%
ATR (14)0.0418 EUR
Vol Ratio (20d)1.99x
52W Range
0.115023% of range0.7320
52W High0.7320 EUR
52W Low0.1150 EUR
Profitability
Gross Margin40.03%
EBITDA Margin-53.92%
Profit Margin-1.37%
Oper. Margin-56.57%
ROE-8.52%
ROA-2.14%
Revenue Growth-44.60%
Earnings Growth—
Balance Sheet
Debt/Equity0.56
Current Ratio0.95
Quick Ratio0.85
Book Value/Sh-0.1380 EUR
Cash/Share0.1690 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Ownership
Shares Out.6.61M
Float—
Insiders65.90%
Institutions0.00%
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Company
Market Cap1.52M EUR
Enterprise Value706.16K EUR
Revenue (TTM)5.02M EUR
Gross Profit5.02M EUR
Net Income (TTM)-171.40K EUR
Revenue/Share0.7610 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees37
Last Price0.2590 EUR
CountryFR
SectorHealthcare
IndustryBiotechnology
ISIN—